Cargando…

JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism

Detalles Bibliográficos
Autores principales: Tavakoli, Vahid, Naing, Sundee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383592/
https://www.ncbi.nlm.nih.gov/pubmed/28401106
http://dx.doi.org/10.5045/br.2017.52.1.67
_version_ 1782520303783510016
author Tavakoli, Vahid
Naing, Sundee
author_facet Tavakoli, Vahid
Naing, Sundee
author_sort Tavakoli, Vahid
collection PubMed
description
format Online
Article
Text
id pubmed-5383592
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-53835922017-04-11 JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism Tavakoli, Vahid Naing, Sundee Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017-03 2017-03-27 /pmc/articles/PMC5383592/ /pubmed/28401106 http://dx.doi.org/10.5045/br.2017.52.1.67 Text en © 2017 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Tavakoli, Vahid
Naing, Sundee
JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism
title JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism
title_full JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism
title_fullStr JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism
title_full_unstemmed JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism
title_short JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism
title_sort jak2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383592/
https://www.ncbi.nlm.nih.gov/pubmed/28401106
http://dx.doi.org/10.5045/br.2017.52.1.67
work_keys_str_mv AT tavakolivahid jak2exon12mutationpositivemyeloproliferativeneoplasmassociatedwithrecurrentthromboembolism
AT naingsundee jak2exon12mutationpositivemyeloproliferativeneoplasmassociatedwithrecurrentthromboembolism